-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOCARE PHARMA - SOFICITINIB ACHIEVES STATISTICALLY SIGNIFICANT PRIMARY AND MULTIPLE SECONDARY ENDPOINTS

Reuters·07/15/2026 11:54:25

Please log in to view news